Arthralgia Induced by BRAF Inhibitor Therapy in Melanoma Patients.

Martin SalzmannKarolina BenesovaKristina Buder-BakhayaDimitrios PapamichailAntonia Dimitrakopoulou-StraussHanns-Martin LorenzAlexander H EnkJessica C Hassel

Published in: Cancers (2020)

Arthralgia is a common side effect in patients receiving BRAFi +/- MEKi therapy and often presents a clinical pattern similar to that observed in RA patients. Its occurrence was associated with longer-lasting tumor control.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
stem cells
patient reported outcomes
bone marrow
disease activity
skin cancer